Hironic Co., Ltd. (KOSDAQ:149980)
4,840.00
-220.00 (-4.35%)
At close: May 29, 2026
Hironic Revenue
Hironic had revenue of 9.59B KRW in the quarter ending March 31, 2026, with 28.04% growth. This brings the company's revenue in the last twelve months to 34.19B, up 9.46% year-over-year. In the year 2025, Hironic had annual revenue of 32.09B with 1.45% growth.
Revenue (ttm)
34.19B
Revenue Growth
+9.46%
P/S Ratio
2.43
Revenue / Employee
292.20M
Employees
117
Market Cap
83.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.09B | 457.26M | 1.45% |
| Dec 31, 2024 | 31.63B | -2.10B | -6.24% |
| Dec 31, 2023 | 33.73B | 6.16B | 22.36% |
| Dec 31, 2022 | 27.57B | 5.79B | 26.57% |
| Dec 31, 2021 | 21.78B | 8.80B | 67.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.27B |
| DRGEM | 106.74B |
| JPI Healthcare | 47.97B |
| L&K Biomed | 39.53B |
| SELVAS Healthcare | 30.19B |
| Remed | 25.24B |
| Dynamic solution | 16.05B |
| MEKICS CO., | 12.26B |